1. Home
  2. GRFS vs LEA Comparison

GRFS vs LEA Comparison

Compare GRFS & LEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRFS
  • LEA
  • Stock Information
  • Founded
  • GRFS 1940
  • LEA 1917
  • Country
  • GRFS Spain
  • LEA United States
  • Employees
  • GRFS N/A
  • LEA N/A
  • Industry
  • GRFS Biotechnology: Pharmaceutical Preparations
  • LEA Auto Parts:O.E.M.
  • Sector
  • GRFS Health Care
  • LEA Consumer Discretionary
  • Exchange
  • GRFS Nasdaq
  • LEA Nasdaq
  • Market Cap
  • GRFS 5.1B
  • LEA 5.3B
  • IPO Year
  • GRFS 2006
  • LEA N/A
  • Fundamental
  • Price
  • GRFS $7.27
  • LEA $87.93
  • Analyst Decision
  • GRFS
  • LEA Buy
  • Analyst Count
  • GRFS 0
  • LEA 11
  • Target Price
  • GRFS N/A
  • LEA $126.09
  • AVG Volume (30 Days)
  • GRFS 1.2M
  • LEA 926.0K
  • Earning Date
  • GRFS 07-28-2022
  • LEA 04-29-2025
  • Dividend Yield
  • GRFS N/A
  • LEA 3.50%
  • EPS Growth
  • GRFS 283.33
  • LEA N/A
  • EPS
  • GRFS 0.24
  • LEA 8.97
  • Revenue
  • GRFS $7,467,006,939.00
  • LEA $23,306,000,000.00
  • Revenue This Year
  • GRFS $8.45
  • LEA N/A
  • Revenue Next Year
  • GRFS $7.08
  • LEA $3.78
  • P/E Ratio
  • GRFS $35.68
  • LEA $9.81
  • Revenue Growth
  • GRFS 9.41
  • LEA N/A
  • 52 Week Low
  • GRFS $5.79
  • LEA $86.28
  • 52 Week High
  • GRFS $9.96
  • LEA $145.35
  • Technical
  • Relative Strength Index (RSI)
  • GRFS 37.73
  • LEA 35.66
  • Support Level
  • GRFS $7.13
  • LEA $92.50
  • Resistance Level
  • GRFS $7.81
  • LEA $97.62
  • Average True Range (ATR)
  • GRFS 0.24
  • LEA 3.01
  • MACD
  • GRFS -0.11
  • LEA -0.67
  • Stochastic Oscillator
  • GRFS 13.33
  • LEA 9.35

About GRFS Grifols S.A.

As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and following the firm's Biotest acquisition in April 2022, the biopharma business contributed 84% of sales in 2023. Grifols also has smaller segments including diagnostics (10% of sales) and biosupplies.

About LEA Lear Corporation

Lear Corp designs, develops, and manufactures automotive seating and electrical systems and components. The company has two reporting segments Seating and E-Systems. Seating components include frames and mechanisms, covers (leather and woven fabric), seat heating and cooling, foam, and headrests. Automotive electrical distribution and connection systems and electronic systems include wiring harnesses, terminals and connectors, on-board battery chargers, high-voltage battery management systems. The company earns most of its revenue from the seating segment.

Share on Social Networks: